Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle

Endocrinology. 1992 Jun;130(6):3625-32. doi: 10.1210/endo.130.6.1375905.

Abstract

To evaluate secretion of mitogenic factors by ovine corpora lutea (CL) at several stages of development, luteal explants from days 5 (n = 12 ewes), 10 (n = 6 ewes), and 15 (n = 6 ewes) of the estrous cycle were incubated in serum-free medium for 24 h. Luteal-conditioned media (LCM) were evaluated for their ability to stimulate proliferation of endothelial, BALB/3T3, and ovarian granulosa cells. After mitogenic activity of LCM from individual animals was evaluated, pools of LCM from each day of the estrous cycle were subjected to anion-exchange, cation-exchange, and heparin-affinity chromatography to characterize mitogenic activity. Pools of LCM also were utilized for ultrafiltration, heat-treatment, trypsin-treatment, and immunoneutralization studies. Results demonstrated that ovine CL secrete mitogenic activity that stimulates (P less than 0.01) proliferation of endothelial (135.7 +/- 5.3% of control) and granulosa cells (188.9 +/- 2.9%) but not 3T3 (103.2 +/- 2.5%) cells. Differences between stages of luteal development were not observed. The mitogenic activity bound to diethylaminoethyl-Sephacel and heparin-agarose, but not to carboxymethyl-Sepharose, indicating that ovine luteal mitogenic factor(s) is anionic and may belong to the heparin-binding growth factor (HBGF) family. In addition, the mitogenic activity was heat-labile, trypsin-sensitive, and appeared to have a M(r) greater than 100,000. Mitogenic activity for endothelial cells was partially neutralized with a specific antibody against HBGF-1 and was completely abolished with a specific antibody against HBGF-2. Moreover, HBGF-1 and HBGF-2 were immunolocalized in histological sections of CL from days 5 (n = 5 ewes), 10 (n = 5 ewes), and 15 (n = 5 ewes) after estrus. These findings are the first report of a major mitogenic factor(s) produced by cyclic ovine CL and indicate this factor is an HBGF-2-like molecule.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 3T3 Cells
  • Animals
  • Cell Division / drug effects
  • Cells, Cultured
  • Chromatography, Affinity
  • Chromatography, Ion Exchange
  • Corpus Luteum / physiology*
  • Culture Media, Serum-Free
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Estrus / physiology*
  • Female
  • Fibroblast Growth Factor 1 / biosynthesis*
  • Fibroblast Growth Factor 1 / metabolism
  • Fibroblast Growth Factor 1 / pharmacology
  • Fibroblast Growth Factor 2 / biosynthesis*
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblast Growth Factor 2 / pharmacology
  • Granulosa Cells / cytology
  • Granulosa Cells / drug effects
  • Mice
  • Mitogens / biosynthesis*
  • Mitogens / metabolism
  • Mitogens / pharmacology
  • Organ Culture Techniques
  • Sheep

Substances

  • Culture Media, Serum-Free
  • Mitogens
  • Fibroblast Growth Factor 2
  • Fibroblast Growth Factor 1